Devon Ends Strategic Review Without Sale; Activists Cry Foul
DVN sits 34% above its 52-week low of $32.06.
Summary
Devon wrapped up its strategic review and decided not to sell more assets, instead focusing on the Permian while keeping Anadarko, Marcellus and Rockies. That drew fresh fire from Kimmeridge's Mark Viviano, who said the retained assets dilute focus and that a whole-company sale should be pursued; Toms Capital said it is "profoundly disappointed" and expects the board to engage interested buyers. The push follows Toms Capital's September letter and the $4.2B Eagle Ford sale to Crescent in October. Q3 results landed the same day: net profit $1.01B ($0.88/share), revenue up 58% to $6.86B and production nearly doubled to 1.66M boe/day on Coterra. Analyst Gabriele Sorbara flagged soft Q3 oil production and Q4 guidance as a source of stock pressure. The board's refusal to sell the whole company keeps the activist fight alive, and any credible bid would be the next thing that matters.
At the time of this announcement, DVN was trading at $42.83 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $47.1B. The 52-week trading range was $32.06 to $52.71. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.